Barclays lowered the firm’s price target on Arvinas (ARVN) to $32 from $48 and keeps an Overweight rating on the shares. The firm says it de-risked the company’s model further by reducing the first line contribution, yet it still sees significant upside in the shares. With the stock trading at 1.4-times cash, Barclays likes the risk/reward.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARVN: